Plaquenil 200 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FFG9H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,904
Award facts
- Contract value 100% obligated
- $1,903.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Plaquenil 200 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,903.56. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive federal contract portfolio encompasses a broad range of pharmaceutical products and medical supplies delivered through the DLA's Medical Supply Chain. The underlying SPE2DX IDC functions as a global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and other medical commodities to support military healthcare programs worldwide, with potential expansion through planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DR26FFG9H?
SPE2DR26FFG9H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FFG9H worth?
The government has obligated $1,904 on SPE2DR26FFG9H.
Is contract SPE2DR26FFG9H an order under another contract?
Yes. SPE2DR26FFG9H is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFG9H competed?
The extent of competition for SPE2DR26FFG9H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award